Skip to content

All recalls FDA

FDADrugsRecalled Status: Completed

Imprimis NJOF, LLC recalls Epinephrine Lidocaine HCL

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Sub-Potent Drug: Subpotent assay results during stability testing.
Products
  • Epinephrine Lidocaine HCL
Where it was sold

Nationwide in the USA

Nationwide

Units affected
6,880 vials
About this recall
Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01